These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6405744)

  • 21. Human pancreatic tumor GH-releasing factor.
    Thorner MO; Evans WS; Vance M; Borges JL; Blizzard RM; Rogol AD; MacLeod RM; Cronin MJ; Frohman LA; Thominet JL
    Acta Neurochir (Wien); 1985; 75(1-4):72-80. PubMed ID: 2986423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factor.
    Arimura A; Culler MD; Turkelson CM; Luciano MG; Thomas CR; Obara N; Groot K; Rivier J; Vale W
    Peptides; 1983; 4(1):107-10. PubMed ID: 6408622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide.
    Dupre J; Greenidge N; McDonald TJ; Ross SA; Rubinstein D
    Metabolism; 1976 Nov; 25(11):1197-9. PubMed ID: 185484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of gastric inhibitory polypeptide on dispersed pancreatic acinar cells from the guinea pig.
    Sjödin L; Conlon TP
    Acta Physiol Scand; 1984 Sep; 122(1):79-84. PubMed ID: 6209922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cholecystokinin, gastrin, secretin and GIP on sham feeding in the rat.
    Lorenz DN; Kreielsheimer G; Smith GP
    Physiol Behav; 1979 Dec; 23(6):1065-72. PubMed ID: 542516
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute stimulation of ganglionic tyrosine hydroxylase activity by secretin, VIP and PHI.
    Ip NY; Baldwin C; Zigmond RE
    Peptides; 1984; 5(2):309-12. PubMed ID: 6147816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].
    Chatelain P; Deschodt-Lanckman M; De Neef P; Christophe J; Robberecht P
    Arch Int Physiol Biochim; 1979 Oct; 87(4):783-4. PubMed ID: 93901
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of motilin and octapeptide of cholecystokinin on antral and duodenal myoelectric activity in the interdigestive state and during inhibition by secretin and gastric inhibitory polypeptide.
    Castresana M; Lee KY; Chey WY; Yajima H
    Digestion; 1978; 17(4):300-8. PubMed ID: 669076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands.
    Dehaye JP; Christophe J; Ernst F; Poloczek P; Van Bogaert P
    Arch Oral Biol; 1985; 30(11-12):827-32. PubMed ID: 2421696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal control of gastrointestinal motility.
    Thomas PA; Akwari OE; Kelly KA
    World J Surg; 1979 Sep; 3(5):545-52. PubMed ID: 390898
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of cholecystokinin, secretin, and gastric inhibitory polypeptide on insulin release from the isolated perfused rat pancreas.
    Pederson RA; Brown JC
    Can J Physiol Pharmacol; 1979 Nov; 57(11):1233-7. PubMed ID: 519526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.
    Simon B; Kather H
    Gastroenterology; 1978 Apr; 74(4):722-5. PubMed ID: 204535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of salivary duct electrolyte transport in rat and rabbit by physalaemin, VIP, GIP and other enterohormones.
    Denniss AR; Young JA
    Pflugers Arch; 1978 Aug; 376(1):73-80. PubMed ID: 568244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrin, secretin, GIP and VIP alter levels of IL-2 and IFN-gamma in human peripheral blood mononuclear cells under various culture conditions.
    Abdalla EE
    Iran J Immunol; 2008 Jun; 5(2):107-14. PubMed ID: 18523356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man.
    Poitras P; Modigliani R; Bernier JJ
    Gut; 1980 Apr; 21(4):299-304. PubMed ID: 7429291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of age on somatostatin suppression of basal, growth hormone (GH)-releasing factor-stimulated, and dibutyryl adenosine 3',5'-monophosphate-stimulated GH release from rat pituitary cells in monolayer culture.
    Cuttler L; Welsh JB; Szabo M
    Endocrinology; 1986 Jul; 119(1):152-8. PubMed ID: 2873023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human pancreatic growth hormone-releasing factor-40 (hpGRF-40) allows stimulation of GH release by TRH.
    Borges JL; Uskavitch DR; Kaiser DL; Cronin MJ; Evans WS; Thorner MO
    Endocrinology; 1983 Oct; 113(4):1519-21. PubMed ID: 6413195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits.
    Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T
    Endocrinology; 1983 Dec; 113(6):2081-5. PubMed ID: 6139274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M; Akiyoshi H; Fujii S
    J Biochem; 1977 Oct; 82(4):1073-6. PubMed ID: 924981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone response of steers injected with synthetic human pancreatic growth hormone-releasing factors.
    Moseley WM; Krabill LF; Friedman AR; Olsen RF
    J Anim Sci; 1984 Feb; 58(2):430-5. PubMed ID: 6423603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.